Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRODIGY: 24-month vs 6-month DAPT after coronary stenting
NCT00611286Phase 4Completed
- Start
- Dec 2006
- Primary completion
- Dec 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of clopidogrel in coronary artery disease (CAD). Primary endpoint: Composite of death, myocardial infarction, or stroke at 24 months. Started Dec 2006; status: completed.
02
Drugs
clopidogrel
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT00611286.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00611286.